Molecular biology reportsHumansCRISPR-Cas SystemsLeukemiaGene EditingReceptors
CRISPR-Cas9 in leukemia immunotherapy: precision engineering of CAR-T cells and tumor-microenvironment modulation.
Jingli Gong, Hamed Soleimani Samarkhazan, Mohammad Siavashi, Nazli Servatian, Farnaz Pirsavabi
Published: 202510.1007/s11033-025-11235-2
Abstract
Together with base editors, prime editors, and alternative nuclease platforms, CRISPR-Cas9 technology has transformed the field of genetic engineering by providing unprecedented precision in genome editing and creating new opportunities for therapeut…
Preview only. Read the full abstract at the source